000			02100cam a2200301 4500500
005			20250112040114.0
041			_afre
042			_adc
100	1	0	_aBaldeyrou, Marion _eauthor
700	1	0	_a Le Bot, Audrey _eauthor
700	1	0	_a Limonta, Silvia _eauthor
700	1	0	_a Tattevin, Pierre _eauthor
700	1	0	_a Revest, Matthieu _eauthor
245	0	0	_aManagement of fever in neutropenic adult patients with cancer
260			_c2019.
500			_a90
520			_aAlthough less frequent and severe than in a hematological setting, febrile neutropenia (FN) is one of the most feared complications following chemotherapy for solid cancer. Its management must be systematic: i) early detection of life-threatening organ dysfunction; ii) full history and physical examination to identify the site of infection, and a blood culture test carried out; iii) administration of the first dose of empirical antibiotherapy within the first hour after initial presentation; iv) identification of patients suitable for outpatient management. An oral fluoroquinolone plus amoxicillin/clavulanate is recommended as empirical outpatient treatment. Different types of antibiotic treatments are recommended for hospitalized patients, depending on the patient in question's clinical presentation. Whether they are hospitalized or not, a patient's clinical condition must be reassessed regularly in order to adjust the antimicrobial therapy if they remain febrile. Thanks to this systematic approach, patients with NF receive treatment that is perfectly safe and as unrestrictive as possible, and may even be able to receive the treatment as outpatients.
690			_asolid cancer
690			_afebrile neutropenia
690			_amanagement
690			_achemotherapy
690			_asolid cancer
690			_afebrile neutropenia
690			_amanagement
690			_achemotherapy
786	0		_nHépato-Gastro & Oncologie Digestive | 26 | HS1 | 2019-10-01 | p. 34-40 | 2115-3310
856	4	1	_uhttps://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2019-HS1-page-34?lang=en
999			_c175215 _d175215